AC
MRK icon

ASB Consultores’s Merck MRK Stock Holding History

ASB Consultores’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,362
Closed -$266K – 99
2025
Q2 		$266K Buy
3,362
+929
+38% +$73.8K 0.18% 102
2025
Q1 		$218K Buy
2,433
+196
+9% +$18.3K 0.14% 108
2024
Q4 		$223K Buy
2,237
+332
+17% +$34.2K 0.09% 188
2024
Q3 		$216K Sell
1,905
-1,983
-51% -$236K 0.09% 195
2024
Q2 		$481K Sell
3,888
-1,612
-29% -$208K 0.17% 79
2024
Q1 		$726K Buy
5,500
+3,635
+195% +$448K 0.19% 78
2023
Q4 		$203K Sell
1,865
-1,618
-46% -$168K 0.07% 108
2023
Q3 		$359K Sell
3,483
-3,671
-51% -$396K 0.14% 71
2023
Q2 		$826K Sell
7,154
-316
-4% -$35.9K 0.4% 42
2023
Q1 		$795K Sell
7,470
-606
-8% -$65.4K 0.32% 41
2022
Q4 		$896K Sell
8,076
-1,340
-14% -$137K 0.37% 33
2022
Q3 		$811K Buy
9,416
+1,624
+21% +$145K 0.38% 32
2022
Q2 		$710K Sell
7,792
-2,344
-23% -$208K 0.31% 33
2022
Q1 		$832K Hold
10,136
– – 0.35% 39
2021
Q4 		$777K Buy
+10,136
New +$807K 0.38% 46

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ASB Consultores's MRK Position: Q3 2025 in Review

ASB Consultores sold out of Merck (MRK) in Q3 2025, closing a stake of 3,362 shares — an estimated $266K sold.

ASB Consultores first reported a position in MRK in Q4 2021 and held it in 15 quarters. The position peaked at $896K in Q4 2022. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • ASB Consultores reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • ASB Consultores sold 3,362 Merck shares in Q3 2025, an estimated $266K.
  • ASB Consultores first reported a position in Merck in Q4 2021 and held it in 15 quarters.
  • ASB Consultores's Merck position peaked at $896K in Q4 2022.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on ASB Consultores's 13F filing for Q3 2025, filed 4 Nov 2025.